End-of-day quote
Shanghai S.E.
23:00:00 16/05/2024 BST
|
5-day change
|
1st Jan Change
|
25.18
CNY
|
+1.66%
|
|
-4.33%
|
+0.68%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,281
|
10,627
|
9,485
|
9,575
|
-
|
-
|
Enterprise Value (EV)
1 |
8,281
|
10,627
|
9,485
|
9,575
|
9,575
|
9,575
|
P/E ratio
|
25.6
x
|
34.8
x
|
52.1
x
|
18.6
x
|
13.4
x
|
10.9
x
|
Yield
|
-
|
0.64%
|
0.6%
|
1.67%
|
2.42%
|
-
|
Capitalization / Revenue
|
-
|
2.79
x
|
2.17
x
|
1.95
x
|
1.73
x
|
1.53
x
|
EV / Revenue
|
-
|
2.79
x
|
2.17
x
|
1.95
x
|
1.73
x
|
1.53
x
|
EV / EBITDA
|
-
|
22.1
x
|
19.6
x
|
10.3
x
|
7.95
x
|
6.78
x
|
EV / FCF
|
-
|
-12.8
x
|
-10.5
x
|
27.1
x
|
15
x
|
-
|
FCF Yield
|
-
|
-7.79%
|
-9.56%
|
3.69%
|
6.65%
|
-
|
Price to Book
|
-
|
4.58
x
|
3.87
x
|
3.06
x
|
2.36
x
|
2.06
x
|
Nbr of stocks (in thousands)
|
377,651
|
378,756
|
379,232
|
380,268
|
-
|
-
|
Reference price
2 |
21.93
|
28.06
|
25.01
|
25.18
|
25.18
|
25.18
|
Announcement Date
|
29/03/22
|
03/04/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
3,804
|
4,369
|
4,918
|
5,529
|
6,244
|
EBITDA
1 |
-
|
481.2
|
484.5
|
934
|
1,205
|
1,412
|
EBIT
1 |
-
|
334.5
|
219.9
|
599
|
763.4
|
1,025
|
Operating Margin
|
-
|
8.79%
|
5.03%
|
12.18%
|
13.81%
|
16.42%
|
Earnings before Tax (EBT)
1 |
-
|
332.3
|
219
|
598.5
|
762.9
|
1,025
|
Net income
1 |
278
|
300.2
|
183.7
|
516.1
|
664.9
|
878.1
|
Net margin
|
-
|
7.89%
|
4.2%
|
10.49%
|
12.03%
|
14.06%
|
EPS
2 |
0.8571
|
0.8071
|
0.4800
|
1.355
|
1.882
|
2.310
|
Free Cash Flow
1 |
-
|
-827.9
|
-907.1
|
353
|
637
|
-
|
FCF margin
|
-
|
-21.77%
|
-20.76%
|
7.18%
|
11.52%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
37.8%
|
52.87%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
68.4%
|
95.8%
|
-
|
Dividend per Share
2 |
-
|
0.1786
|
0.1500
|
0.4200
|
0.6100
|
-
|
Announcement Date
|
29/03/22
|
03/04/23
|
25/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
2023 Q2
|
---|
Net sales
1 |
-
|
1,141
|
EBITDA
|
-
|
-
|
EBIT
|
-
|
-
|
Operating Margin
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
1 |
29.22
|
80.82
|
Net margin
|
-
|
7.08%
|
EPS
|
0.0786
|
-
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
26/04/23
|
11/08/23
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-828
|
-907
|
353
|
637
|
-
|
ROE (net income / shareholders' equity)
|
-
|
13.7%
|
7.14%
|
16.5%
|
19%
|
18.9%
|
ROA (Net income/ Total Assets)
|
-
|
6.78%
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
4,430
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
6.120
|
6.460
|
8.230
|
10.70
|
12.20
|
Cash Flow per Share
2 |
-
|
1.160
|
1.380
|
1.800
|
2.900
|
2.950
|
Capex
1 |
-
|
1,270
|
1,431
|
600
|
370
|
394
|
Capex / Sales
|
-
|
33.38%
|
32.75%
|
12.19%
|
6.7%
|
6.31%
|
Announcement Date
|
29/03/22
|
03/04/23
|
25/04/24
|
-
|
-
|
-
|
Last Close Price
25.18
CNY Average target price
39.15
CNY Spread / Average Target +55.48% Consensus |
1st Jan change
|
Capi.
|
---|
| +0.68% | 1.3B | | +5.41% | 105B | | -3.11% | 64.71B | | +73.33% | 49.72B | | +17.24% | 38.6B | | +6.13% | 32.54B | | +12.77% | 19.94B | | +15.03% | 16.92B | | +19.06% | 15.2B | | +6.28% | 14.39B |
Other Commodity Chemicals
|